View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports

Pandora A/S: Update following rating affirmation

Our credit view of this issuer reflects its good geographical and channel mixes, strong credit metrics, offset by execution risks related to its transition to platinum-plated products.

ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Sten Gustafsson
ABGSC Healthcare Research ... (+3)
  • ABGSC Healthcare Research
  • Georg Tigalonov-Bjerke
  • Sten Gustafsson

Pandora AS: 1 director

A director at Pandora AS bought 500 shares at 539.000DKK and the significance rating of the trade was 61/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly show...

 PRESS RELEASE

Aktietilbagekøb: Transaktioner i uge 7 2026

Aktietilbagekøb: Transaktioner i uge 7 2026 Aktietilbagekøbsprogrammet løber i perioden fra og med den 5. februar 2026 til senest den 29. januar 2027. I denne periode vil Jyske Bank erhverve egne aktier til en maksimal værdi af 3 mia. kr. i et aktietilbagekøbsprogram, jf. selskabsmeddelelse nr. 11/2026 af 5. februar 2026. Aktietilbagekøbsprogrammet gennemføres i henhold til EU‑Kommissionens forordning (EU) nr. 596/2014 af 16. april 2014, også kaldet “markedsmisbrugsforordningen”, og EU‑Kommissionens delegerede forordning (EU) 2016/1052 af 8. marts 2016 (tilsammen “safe harbour‑reglerne”). ...

 PRESS RELEASE

Share repurchase programme: Transactions of week 7 2026

Share repurchase programme: Transactions of week 7 2026 The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The ...

Moody's Ratings affirms Pandora's Baa2 ratings; Outlook stable

Moody's Ratings (Moody's) has today affirmed Pandora A/S's (Pandora) Baa2 long term issuer ratings, its Baa2 senior unsecured ratings and (P)Baa2 senior unsecured MTN ratings. The outlook remains stable. "Pandora's rating affirmation underscores its robust credit metrics, strong market position, a...

ABGSC Construct. & Real Estate Research ... (+3)
  • ABGSC Construct. & Real Estate Research
  • Bengt Jonassen
  • Herman Caspersen

Selvaag Bolig ASA: 5 directors

Five Directors at Selvaag Bolig ASA sold 550,888 shares at between 33.590NOK and 34.220NOK. The significance rating of the trade was 69/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over ...

 PRESS RELEASE

Coloplast A/S - Opdateret finanskalender 2025-26

Coloplast A/S - Opdateret finanskalender 2025-26 Venligst se vedlagte pdf.  Opdatering af datoer i finanskalenderen Coloplast har opdateret datoerne i selskabets finanskalender vedrørende offentliggørelsen af årsregnskabet for 2025/26 samt afholdelsen af den ordinære generalforsamling 2026. De opdaterede datoer er som følger: Årsregnskabsmeddelelse for 2025/26 og Årsrapport 2025/26: ændret fra 5. november 2026 til 3. november 2026Ordinær generalforsamling 2026: ændret fra 3. december 2026 til 1. december 2026 For yderligere information og kalenderinvitationer til kommende beg...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ABGSC Construct. & Real Estate Research ... (+3)
  • ABGSC Construct. & Real Estate Research
  • Bengt Jonassen
  • Herman Caspersen
 PRESS RELEASE

Indkaldelse til ordinær generalforsamling i Jyske Bank A/S

Indkaldelse til ordinær generalforsamling i Jyske Bank A/S Jyske Bank A/S afholder ordinær generalforsamling tirsdag, den 17. marts 2026, kl. 15.00 på Gl. Skovridergaard, Marienlundsvej 36, 8600 Silkeborg, med følgende DAGSORDEN for generalforsamlingen: a.Bestyrelsens beretning om bankens virksomhed i det forløbne år.b.Forelæggelse af årsrapport til godkendelse eller anden beslutning samt beslutning om anvendelse af overskud eller dækning af tab i henhold til det godkendte regnskab, herunder bestyrelsens forslag om udbetaling af udbytte.c.Præsentation af og vejledende afstemning om vederla...

 PRESS RELEASE

Notice of Annual General Meeting of Jyske Bank A/S

Notice of Annual General Meeting of Jyske Bank A/S This is to give notice of an Annual General Meeting of Jyske Bank A/S, which will be held on Tuesday 17 March 2026, at 3.00 p.m. at Gl. Skovridergaard, Marienlundsvej 36, DK-8600 Silkeborg AGENDA of general meeting: a.Report of the Supervisory Board on Jyske Bank's operations during the preceding year.b.Presentation of the annual report for adoption or other resolution as well as resolution as to the application of profit or cover of loss according to the financial statements adopted, including the Supervisory Board’s proposal for payment ...

 PRESS RELEASE

Aktietilbagekøb: Transaktioner i uge 6 2026

Aktietilbagekøb: Transaktioner i uge 6 2026 Aktietilbagekøbsprogrammet løber i perioden fra og med den 5. februar 2026 til senest den 29. januar 2027. I denne periode vil Jyske Bank erhverve egne aktier til en maksimal værdi af 3 mia. kr. i et aktietilbagekøbsprogram, jf. selskabsmeddelelse nr. 11/2026 af 5. februar 2026. Aktietilbagekøbsprogrammet gennemføres i henhold til EU‑Kommissionens forordning (EU) nr. 596/2014 af 16. april 2014, også kaldet “markedsmisbrugsforordningen”, og EU‑Kommissionens delegerede forordning (EU) 2016/1052 af 8. marts 2016 (tilsammen “safe harbour‑reglerne”). ...

 PRESS RELEASE

Share repurchase programme: Transactions of week 6 2026

Share repurchase programme: Transactions of week 6 2026 The share repurchase programme runs as from 5 February 2026 and up to and including 29 January 2027 at the latest. In this period, Jyske Bank will acquire shares with a value of up to DKK 3 billion, cf. Corporate Announcement No. 11/2026 of 5 February 2026. The share repurchase programme is initiated and structured in compliance with the Market Abuse Regulation (Regulation (EU) No 596/2014) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016 (together with the Market Abuse Regulation, the “Safe Harbour Rules”). The ...

ABGSC Healthcare Research ... (+2)
  • ABGSC Healthcare Research
  • Morten Larsen
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch